Janux Therapeutics, Inc. — All Filings
408 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0000950170-25-058806 | Apr 25, 2025 | — |
| DEFA14A | DEFA14A | 0000950170-25-058809 | Apr 25, 2025 | — |
| ARS | ARS | 0000950170-25-058822 | Apr 25, 2025 | — |
| 4 | — | 0001415889-25-011243 | Apr 23, 2025 | Apr 21, 2025 |
| 144 | — | 0001950047-25-002522 | Apr 21, 2025 | — |
| SCHEDULE 13D/A | — | 0001415889-25-007529 | Mar 10, 2025 | — |
| 4 | — | 0001415889-25-007443 | Mar 7, 2025 | Mar 5, 2025 |
| 4 | — | 0001415889-25-007104 | Mar 5, 2025 | Mar 3, 2025 |
| 144 | — | 0001950047-25-001426 | Mar 3, 2025 | — |
| 8-K | 8-K | 0000950170-25-029165 | Feb 27, 2025 | — |
| 10-K | 10-K | 0000950170-25-029177 | Feb 27, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0000950170-25-029185 | Feb 27, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-014233 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-000855 | Feb 12, 2025 | — |
| 4 | — | 0001415889-25-003165 | Feb 5, 2025 | Feb 3, 2025 |
| 144 | — | 0001950047-25-000570 | Feb 3, 2025 | — |
| 4 | — | 0001415889-25-001165 | Jan 8, 2025 | Jan 7, 2025 |
| 144 | — | 0001949846-25-000005 | Jan 7, 2025 | — |
| 4 | — | 0001415889-25-000675 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000554 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000676 | Jan 3, 2025 | Jan 2, 2025 |
| 3 | — | 0001415889-25-000668 | Jan 3, 2025 | Jan 1, 2025 |
| 3/A | — | 0001415889-25-000669 | Jan 3, 2025 | Jan 1, 2023 |
| 4 | — | 0001415889-25-000672 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000677 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000674 | Jan 3, 2025 | Jan 2, 2025 |
| 4 | — | 0001415889-25-000673 | Jan 3, 2025 | Jan 2, 2025 |
| 144 | — | 0001950047-25-000049 | Jan 2, 2025 | — |
| 4 | — | 0001415889-24-030211 | Dec 27, 2024 | Dec 24, 2024 |
| 144 | — | 0001949846-24-000838 | Dec 26, 2024 | — |
| 4 | — | 0001415889-24-029989 | Dec 20, 2024 | Dec 19, 2024 |
| 424B5 | 424B5 | 0001193125-24-271563 | Dec 5, 2024 | — |
| 8-K | 8-K | 0001193125-24-271578 | Dec 5, 2024 | Dec 4, 2024 |
| 424B5 | 424B5 | 0001193125-24-270017 | Dec 3, 2024 | — |
| 4 | — | 0001415889-24-028203 | Dec 3, 2024 | — |
| 8-K | 8-K | 0000950170-24-132302 | Dec 2, 2024 | — |
| 4 | — | 0001415889-24-027905 | Nov 27, 2024 | Nov 25, 2024 |
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0000921895-24-002714 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-118952 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-258521 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000315066-24-002789 | Nov 12, 2024 | — |
| SC 13D/A | SC 13D/A | 0001104659-24-116001 | Nov 8, 2024 | — |
| 4 | — | 0001415889-24-026385 | Nov 7, 2024 | Nov 5, 2024 |
| 4 | — | 0001415889-24-026386 | Nov 7, 2024 | Nov 5, 2024 |
| 10-Q | 10-Q | 0000950170-24-122370 | Nov 6, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0000950170-24-122279 | Nov 6, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-250609 | Nov 4, 2024 | — |
| 144 | — | 0001957799-24-000299 | Nov 1, 2024 | — |
| 144 | — | 0001957799-24-000300 | Nov 1, 2024 | — |
| 144 | — | 0001972362-24-001466 | Nov 1, 2024 | — |